Dr. Indira Mysorekar

7.8K posts

Dr. Indira Mysorekar banner
Dr. Indira Mysorekar

Dr. Indira Mysorekar

@MysorekarLab

Professor & Chief, Infectious Diseases, Passionate about research in #UTIs #viralInfections #autophagy #bladder #placenta #aging #immunity #translationalres

Houston, TX Katılım Ağustos 2017
2.1K Takip Edilen2.7K Takipçiler
Cory Miller
Cory Miller@CoryMillerMarmo·
A new paper out from the lab on prosocial behaviors in marmosets: rdcu.be/e4dst . This paper is from an undergrad led study from start to finish. Anand Mysorekar did an incredible job with the project.
English
1
0
11
1.3K
Dr. Indira Mysorekar retweetledi
CAIRIBU
CAIRIBU@CAIRIBU1·
The next Uro-Aging RIG Knowledge Exchange will feature Aruna Sarma, PhD, MHA (University of Michigan) who will present "Urologic Complications in Diabetes- Long term findings." More information: buff.ly/PAiV1fy
CAIRIBU tweet media
English
0
1
2
227
Dr. Indira Mysorekar retweetledi
Dr. Rafael Michita
Dr. Rafael Michita@Michita_Rafael·
I’m beyond honored to be named one of 🎉 STAT 2025 Wunderkinds. Endless thanks to my mentor @MysorekarLab, labmates, and everyone who believed in this mission long before it had a name. The best is yet to come! #STATWunderkinds @statnews @BCMDeptMedicine
From the Labs at Baylor College of Medicine@BCMFromtheLabs

Congratulations, Dr. Rafael Tomoya Michita @Michita_Rafael, BCM's 2025 Wunderkind! #BCMPostdoc @MysorekarLab @statnews @BCMDeptMedicine @bcmhouston #ZikaVirus bcm.edu/news/dr-rafael…

English
2
2
7
995
Dr. Indira Mysorekar retweetledi
SRI
SRI@SRIWomensHealth·
This past Friday, our SEA Fellows had the opportunity to learn from Sangeeta K. Cheema, JD, PhD, Intellectual Property Attorney. In this lecture, Dr. Cheema provided a breakdown of the key steps in preparing biotechnology patent applications & strategic IP portfolio management.
SRI tweet media
English
0
1
1
321
Dr. Indira Mysorekar retweetledi
BCM Clinician Resources
Faculty like Drs. @deepaksharma248 @Michita_Rafael @MysorekarLab and Long Tran inspire our work in CME. @BCMFromtheLabs shared their review on virus spread in placenta: bit.ly/48fcVrP Once done reading, explore related topics on BCM CR: clinicianresources.bcm.edu/learning/?q=vi… @BCMDeptMedicine
From the Labs at Baylor College of Medicine@BCMFromtheLabs

Interested in how #viruses spread in the #placenta? L Tran, @Michita_Rafael, @deepaksharma248 & @MysorekarLab just published a #review on this topic. sciencedirect.com/science/articl… #CurrOpinionVirol @BCMDeptMedicine @BCMGradSchool

English
0
1
2
331
Dr. Indira Mysorekar retweetledi
SRI
SRI@SRIWomensHealth·
Learn how to protect your innovations and navigate patents & licensing on Oct 3 for the Scientific Entrepreneurship Academy's session, IP Basics for Entrepreneurs, led by industry expert Sangeeta K. Cheema, JD, PhD. Interested in attending? Contact us at info@sri-online.org!
SRI tweet media
English
0
1
2
274
Dr. Indira Mysorekar retweetledi
CAIRIBU
CAIRIBU@CAIRIBU1·
HAPPENING TODAY- CAIRIBU's Uro-Aging Research Interest Group commences! The Uro-Aging Research Interest Group (UroAging RIG) will connect uro-aging interested CAIRIBU and non-CAIRIBU investigators from a variety of fields including but not limited to urology, urogynecology, and geroscience. To kick-start this group, we are scheduling monthly knowledge exchanges to know each other, discuss recent research, develop collaborations, and strategize on ways to advance uro-aging research. Join our first knowledge exchange on Monday, September 22 at 3:00 PM ET to hear from Indira Mysorekar, PhD (Baylor College of Medicine) and Scott Bauer, MD, MS (University of California, San Francisco) who will kick off this series by reviewing the field of uro-aging research and stimulating discussion on a collaborative, interdisciplinary research agenda. More info: buff.ly/79b86Xf
CAIRIBU tweet media
English
0
2
3
200
Dr. Indira Mysorekar retweetledi
SRI
SRI@SRIWomensHealth·
This morning, our SEA Fellows heard from the incredible Eric Schaefer, Senior Director, Portfolio Strategy & Investment at @MarchofDimes. Eric aided our fellows in understanding how to navigate different types of funding strategies & how to pitch their innovation to investors.
SRI tweet media
English
1
1
1
294
Dr. Indira Mysorekar retweetledi
Anirban Maitra
Anirban Maitra@Aiims1742·
This is HUGE! No embargo needed for @AACR publications deposited in PubMed Central - enabling compliance with the NIH public access policy without spending exorbitant open access fees.
Elizabeth McKenna@ElizSMcKenna

You can read the AACR journals' policy here: #funder" target="_blank" rel="nofollow noopener">aacrjournals.org/pages/open-acc… "The Author Accepted Manuscript is permitted to be deposited in PMC and made available to the public on or after the first online publication date of the Version of Record."

English
1
16
79
9.1K
Dr. Indira Mysorekar retweetledi
Sarah Ross
Sarah Ross@sarah_h_ross·
Tissue immunity meets biological sex differences - context is important in the immune system. Another of my reading recommendations during a trip to @iuis_online Congress. From Sonia Sharma, Alicia Gibbons and @EOSaphire in @ScienceMagazine buff.ly/XPN0Tpb
Sarah Ross tweet media
English
3
77
342
45.2K
Dr. Indira Mysorekar retweetledi
UTI Global Alliance
UTI Global Alliance@GlobalUti·
🚨🚨ATTENTION TO OUR FRIENDS DOWN UNDER 🦘🇦🇺🐨 @MonashUni will be hosting an in-person and virtual symposium on bladder and kidney health 10/24/25! Many #UTIGA members will be speaking and attending. This will be a great opportunity to network and learn 💖 @ChronicUTIAus
UTI Global Alliance tweet media
English
0
6
7
1.4K
Dr. Indira Mysorekar retweetledi
Amer. Urol. Assn.
Amer. Urol. Assn.@AmerUrological·
AUA’s @drrachelrubin recently joined an FDA panel to advocate for removing the FDA black box warning on low-dose vaginal estrogen. We stand with Dr. Rubin and the broader medical community for the removal of this outdated label that undermines safe, effective care for women with GSM. #AUAadvocacy Learn more 👉 bit.ly/3UL6jcu
English
4
12
42
3.7K
Dr. Indira Mysorekar retweetledi
Andrei Thomas-T.
Andrei Thomas-T.@andrei_thomas_t·
This just in… FY’26 Bill Highlights: National Institutes of Health: $48.7 billion for biomedical investments in research. Cancer: $7.4 billion for the National Cancer Institute, including $28 million for the Childhood Cancer STAR Act. statnews.com/2025/07/31/nih…
English
0
9
16
2.3K